STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to compare the effects on participants' and liver cancer by adding a drug that is used on its own to treat this disease to a combination of two other drugs which is also used to treat liver cancer, compared to the two-drug combination alone.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Masa ciała powyżej 30 kg
- •Oczekiwana długość życia co najmniej 12 tygodni
- •Potwierdzony rak wątroby (badaniem tkanki lub obrazowaniem)
- •Rak wątroby, którego nie można operować
- •Brak poprzedniego leczenia systemowego tego raka
- •Dobry stan ogólny pacjenta (ECOG 0 lub 1)
- •Dobna funkcja wątroby (klasa Child-Pugh A lub B7)
✗ Disqualifies
- •Poprzednie leczenie systemowe raka wątroby
- •Kwalifikacja do leczenia lokalnego (wlewu, napromieniania)
- •Zaawansowana niewydolność wątroby (klasa Child-Pugh C)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (12)
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Canada
BCCA - Vancouver
Vancouver, Canada
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Canada
Kingston Health Sciences Centre
Kingston, Canada
Waterloo Regional Health Network (WRHN)
Kitchener, Canada
London Health Sciences Centre Research Inc.
London, Canada
Trillium Health Partners - Credit Valley Hospital
Mississauga, Canada
Ottawa Hospital Research Institute
Ottawa, Canada
University Health Network
Toronto, Canada
CHUM-Centre Hospitalier de l'Universite de Montreal
Montreal, Canada
The Jewish General Hospital
Montreal, Canada
Saskatoon Cancer Centre
Saskatoon, Canada
Trial contact
Chris O'Callaghan
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.